Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Adrenergic receptor alpha-1 | Starlite/ChEMBL | References |
Rattus norvegicus | Adrenergic receptor alpha-2 | Starlite/ChEMBL | References |
Rattus norvegicus | Dopamine receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | biogenic amine (5HT) receptor | Adrenergic receptor alpha-2 | 450 aa | 433 aa | 27.9 % |
Echinococcus multilocularis | fmrfamide receptor | Adrenergic receptor alpha-2 | 450 aa | 366 aa | 19.9 % |
Schistosoma mansoni | amine GPCR | Adrenergic receptor alpha-2 | 450 aa | 439 aa | 29.2 % |
Schistosoma japonicum | ko:K04136 adrenergic receptor, alpha 1b, putative | Dopamine receptor | 475 aa | 405 aa | 33.3 % |
Schistosoma japonicum | ko:K04207 neuropeptide Y receptor Y5, putative | Adrenergic receptor alpha-2 | 450 aa | 378 aa | 20.9 % |
Echinococcus multilocularis | neuropeptides capa receptor | Adrenergic receptor alpha-2 | 450 aa | 486 aa | 20.6 % |
Schistosoma japonicum | ko:K04135 adrenergic receptor, alpha 1a, putative | Dopamine receptor | 475 aa | 398 aa | 34.2 % |
Echinococcus multilocularis | alpha 1A adrenergic receptor | Adrenergic receptor alpha-2 | 450 aa | 478 aa | 20.7 % |
Echinococcus multilocularis | serotonin receptor | Adrenergic receptor alpha-2 | 450 aa | 426 aa | 31.9 % |
Onchocerca volvulus | Adrenergic receptor alpha-2 | 450 aa | 467 aa | 25.1 % | |
Echinococcus granulosus | alpha 1A adrenergic receptor | Adrenergic receptor alpha-2 | 450 aa | 476 aa | 21.0 % |
Onchocerca volvulus | Adrenergic receptor alpha-2 | 450 aa | 420 aa | 19.8 % | |
Loa Loa (eye worm) | TYRA-2 protein | Adrenergic receptor alpha-2 | 450 aa | 488 aa | 23.8 % |
Schistosoma japonicum | ko:K04145 dopamine receptor D2, putative | Adrenergic receptor alpha-2 | 450 aa | 473 aa | 24.1 % |
Echinococcus granulosus | biogenic amine 5HT receptor | Adrenergic receptor alpha-2 | 450 aa | 423 aa | 31.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | High cysteine membrane protein Group 2 | 0.0109 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0293 | 1 | 1 |
Echinococcus multilocularis | 0.0236 | 0.6922 | 1 | |
Loa Loa (eye worm) | endoprotease bli-4 | 0.0293 | 1 | 1 |
Brugia malayi | celfurPC protein | 0.0236 | 0.6922 | 0.4795 |
Echinococcus granulosus | furin | 0.0293 | 1 | 1 |
Echinococcus multilocularis | neuroendocrine convertase 2 | 0.0184 | 0.4087 | 0.1038 |
Schistosoma mansoni | subfamily S8B unassigned peptidase (S08 family) | 0.0293 | 1 | 1 |
Echinococcus granulosus | neuroendocrine convertase 2 | 0.0184 | 0.4087 | 0.0526 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0178 | 0.3758 | 0.5 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0178 | 0.3758 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 180 nM | In vitro binding affinity was measured as the inhibition of [3H]-WB-4101 binding to alpha-1 adrenergic receptor of rat cortical membranes | ChEMBL. | 3016265 |
Ki (binding) | = 180 nM | In vitro binding affinity was measured as the inhibition of [3H]-WB-4101 binding to alpha-1 adrenergic receptor of rat cortical membranes | ChEMBL. | 3016265 |
Ki (binding) | = 910 nM | In vitro binding affinity was measured as the inhibition of [3H]-Clonidine binding to alpha-2 adrenergic receptor of rat cortical membranes | ChEMBL. | 3016265 |
Ki (binding) | = 910 nM | In vitro binding affinity was measured as the inhibition of [3H]-Clonidine binding to alpha-2 adrenergic receptor of rat cortical membranes | ChEMBL. | 3016265 |
Ki (binding) | = 1400 nM | In vitro binding affinity to Dopamine receptors of rat striatal membranes by [3H]-spiroperidol displacement. | ChEMBL. | 3016265 |
Ki (binding) | = 1400 nM | In vitro binding affinity to Dopamine receptors of rat striatal membranes by [3H]-spiroperidol displacement. | ChEMBL. | 3016265 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.